Startup Advances to Showcase and $300K Final Competition at the Asia Pacific MedTech Forum in Singapore
SHANGHAI and LOS ANGELES, Sept. 9, 2019 –
MedTech Innovator, the premier global nonprofit accelerator in the medical technology industry, today announced that Wision A.I. has been selected as the winner at the organization’s Shanghai regional pitch event, hosted by JLABS @ Shanghai. Wision A.I. now advances to the 2019 MedTech Innovator Asia Pacific Showcase Program, featuring 20 best-in-class startups from the Asia Pacific region developing transformative medical solutions to improve the lives of patients.
MedTech Innovator launched its Asia Pacific Program this year in partnership with Asia Pacific Medical Technology Association (APACMed) to accelerate the growth of the most promising medical device, digital health, and diagnostic startups in the region. Pitch events were also held in Tokyo, Sydney and Singapore.
Wision A.I. has developed computer aided diagnosis solutions for gastrointestinal endoscopy. The first product of AI colonoscopy could significantly increase the adenoma detection rate (ADR), which is the key performance indicator in colon cancer screening, and every 1% of ADR increase will result 3% decrease of interval colon cancer. As the Shanghai pitch event winner, Wision A.I. will present in the MedTech Innovator Showcase at the Fifth Annual Asia Pacific MedTech Forum October 8 and 9 in Singapore.
“I am grateful that MedTech Innovator has established such a fabulous platform for the startups to showcase and to get insightful feedback from the judges,” said JingJia Liu, CEO of Wision A.I. “This platform is pushing the frontier of medical innovations, and Wision A.I. is committed to clinical value of artificial intelligence in the endoscopy. We look forward to participating in the coming MedTech Innovator Asia Pacific Showcase in Singapore.”
The company will receive mentoring by MedTech Innovator’s Asia Pacific corporate partners including Johnson & Johnson, Amgen, Boston Scientific, JOHNAN, Olympus Medical Systems Group, and Terumo. Wision A.I. is also one of 20 semi-finalists competing for four spots in the 2019 Grand Finals competition at the MedTech Forum, with up to $300,000 in non-dilutive cash prizes and awards.
“We are pleased that Wision AI was chosen by regional industry leaders as the winner of the Shanghai pitch event,” said Jenell Robinson, Head of MedTech Innovator Asia Pacific. “Our goal in MedTech Innovator Asia Pacific is to find the most promising startups from across the Asia Pacific region and to give them access to our industry-leading corporate partners and world class ecosystem. We aim to ensure that their transformative health technologies reach patients and improve lives.”
“The Asia Pacific Innovation Center of Johnson & Johnson Innovation is proud to be able to support MedTech Innovator Asia Pacific in discovering breakthrough innovations in the region as part of our strong commitment to nurturing the healthcare ecosystem,” said Dan Wang, Head of Johnson & Johnson Innovation, Asia Pacific. “Medical devices, digital health and diagnosis are key focus areas that have tremendous potential to disrupt and push scientific boundaries.”
“It was impressive to hear from an immensely talented group of medtech start-ups looking to solve some of the toughest healthcare challenges,” said Ralph Cardinal, Head of R&D for Boston Scientific Asia Pacific and a judge at this year’s event. “We are committed to supporting start-ups in this part of the world through our partnership with MedTech Innovator as part of our ongoing commitment to the innovation ecosystem across Asia Pacific.”
Over 170 companies applied for the Asia Pacific program, and seven startups were selected to participate in the Shanghai pitch event. Each company presented in front of a panel of industry judges and an audience of more than 150 attendees at the event hosted by JLABS @ Shanghai. Startups had the opportunity to network with MedTech Innovator’s partners and to pitch their products, business plans, and value propositions to the judges. The judges included:
- Peter Hawkes, Johnson & Johnson Innovation
- Stephen Lee, Johnson & Johnson Innovation
- Prasanna Malaviya, Johnson & Johnson Medical Device
- Ralph Cardinal, Boston Scientific
- Barry Sun, Terumo
- Cyndi Zhai, Joyin Incubator
- Evian Zhu, China National Health Association
- Frank Li, Tianyi Capital
- Jay Yin, Sungent BioVenture
- Jonathan Hakim, ECM Medical
- Mingxi Li, GT Health
- Oscar Zhang, QiMing Venture Partners
- Rebecca Zhu, 6D Capital
- Rob Scott, China BlueSky Partners
- Ruilin Zhao, CD Capital
- William Jin, Warburg Pincus
- Yongqin Zhang, Philips
- Zhang Dan, Fountain Medical
Startups selected to present in the MedTech Innovator Shanghai pitch event included:
- Helios Biosciences
- Novus Medtech
- Wision A.I.
Since 2013, MedTech Innovator has reviewed more than 3,000 startups and graduated 185 companies that have gone on to raise more than $1 billion in follow-on funding and bring 37 products to market. MedTech Innovator’s 2019 Asia Pacific program sponsors include Johnson & Johnson Medical Device Companies, Amgen, Boston Scientific, JOHNAN, Olympus Medical Systems Group, and Terumo. Regional sponsors for the Singapore pitch event are APACMed, Singapore Biodesign, and Enterprise Singapore. The MedTech Innovator Asia Pacific Program is held in partnership with the Asia Pacific Medical Technology Association (APACMed).
About MedTech Innovator
Based in Los Angeles, California, MedTech Innovator is the premier nonprofit startup accelerator in the medical technology industry. Its mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. MedTech Innovator matches healthcare industry leaders with innovative early-stage and emerging growth medtech companies for mentorship and support. For more information about MedTech Innovator, visit https://medtechinnovator.org/ and follow @MedTechAwards on Twitter. To receive industry insights and highlights about MedTech Innovator’s current and alumni participant companies, subscribe to its monthly newsletter.
About Asia Pacific Medical Technology Association
Founded in 2014, the Asia Pacific Medical Technology Association (APACMed 亚太医疗技术协会) is the first and only regional association to provide a unified voice for the medical technology industry in Asia Pacific. APACMed works proactively with bilateral, regional and local government bodies to shape policies, demonstrate the value of innovation and promote regulatory convergence. APACMed engages with medical device associations and companies in Asia Pacific to jointly advance regional issues, code of ethics and share best practices. Learn more about the association at www.apacmed.org.
# # #